Equities

Pacira Biosciences Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Pacira Biosciences Inc

Actions
  • Price (CHF)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta0.2003
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments485279289
Total Receivables, Net11310698
Total Inventory12510496
Prepaid expenses222215
Other current assets, total------
Total current assets745510498
Property, plant & equipment, net216235254
Goodwill, net0163163
Intangibles, net426483541
Long term investments363864
Note receivable - long term------
Other long term assets------
Total assets1,5541,5741,681
LIABILITIES
Accounts payable191615
Accrued expenses786592
Notes payable/short-term debt000
Current portion long-term debt/capital leases2028.6434
Other current liabilities, total118.537.30
Total current liabilities31097148
Total long term debt384514656
Total debt585522689
Deferred income tax------
Minority interest------
Other liabilities, total8293103
Total liabilities775704906
SHAREHOLDERS EQUITY
Common stock0.050.050.05
Additional paid-in capital1,009977924
Retained earnings (accumulated deficit)(206)(107)(149)
Treasury stock - common(25)----
Unrealized gain (loss)0.190.12(0.52)
Other equity, total0.150.120.14
Total equity778870775
Total liabilities & shareholders' equity1,5541,5741,681
Total common shares outstanding464646
Treasury shares - common primary issue0.8400
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.